TITLE

Urinary leukotriene LTE4 levels in non-responders to antileukotriene therapy

AUTHOR(S)
Lee, D. K. C.
PUB. DATE
August 2004
SOURCE
Thorax;Aug2004, Vol. 59 Issue 8, p727
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor on antileukotriene therapy.
ACCESSION #
14197063

 

Related Articles

  • Comments to Metallothionein as an Anti-Inflammatory Mediator. Yong-Song Guan // Mediators of Inflammation;2009, Vol. 2009, Special section p1 

    A letter to the editor about metallothionen as an anti-inflammatory mediator is presented.

  • Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Molina, Daniel Martinez; Wetterholm, Anders; Kohl, Andreas; McCarthy, Andrew A.; Niegowski, Damian; Ohlson, Eva; Hammarberg, Tove; Eshaghi, Said; Haeggström, Jesper Z.; Nordlund, Pär // Nature;8/2/2007 Supplement, Vol. 448 Issue 7153, p613 

    Cysteinyl leukotrienes are key mediators in inflammation and have an important role in acute and chronic inflammatory diseases of the cardiovascular and respiratory systems, in particular bronchial asthma. In the biosynthesis of cysteinyl leukotrienes, conversion of arachidonic acid forms the...

  • Inflammatory Mediators May Have Divergent Roles in Cancer and in Alzheimer's Disease. Metz, R. A.; Balin, B. J.; Abrams, J. T.; Schrogie, J. J. // Clinical Pharmacology & Therapeutics;Oct2010, Vol. 88 Issue 4, p466 

    A letter to the editor is presented in response to topic related to the role of inflammatory mediators in cancer and Alzheimer's disease covered in the April 2010 issue.

  • Authors' Reply to Comments from Dr. Guan. Inoue, Ken-ichiro; Takano, Hirohisa // Mediators of Inflammation;2009, Vol. 2009, Special section p1 

    A response by Ken-ichiro Inoue to a letter to the editor about their article "Metallothionein As an Anti-inflmmatory Mediator,"whihc was published in a 2009 issue is presented.

  • AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Fernandes-Alnemri, Teresa; Yu, Je-Wook; Datta, Pinaki; Wu, Jianghong; Alnemri, Emad S. // Nature;3/26/2009, Vol. 458 Issue 7237, p509 

    Host- and pathogen-associated cytoplasmic double-stranded DNA triggers the activation of a NALP3 (also known as cryopyrin and NLRP3)-independent inflammasome, which activates caspase-1 leading to maturation of pro-interleukin-1β and inflammation. The nature of the cytoplasmic-DNA-sensing...

  • Functional roles of Phe12 of deacetyl-thymosin beta4 in the impaired blastogenic response of uraemic T-lymphocytes. Abiko, T.; Sekino, H. // Mediators of Inflammation;Feb97, Vol. 6 Issue 1, p64 

    PHE12 of deacetyl-thymosin beta4 is one of the structural essentials for restorative effect on the impaired blastogenic response of uraemic T-lymphocytes. In order to evaluate the functional roles of this phenyl group in the restorative effect on impaired T-lymphocytes, two analogues, [1-...

  • Systemic inflammatory response syndrome (SIRS) induced by carbon tetrachloride in rats. Gergely, J.; Sipka, S.; Csipo, J.; Udvardy, M.; Szegedi, Gy.; Kulcsar, A. // Mediators of Inflammation;Feb97, Vol. 6 Issue 1, p73 

    WE have observed the symptoms of systemic inflammatory response syndrome (SIRS) in male rats intoxicated by carbon tetrachloride (CCl4). Severe hypothermia, tachypnoea and increase in the heart beat min were diagnosed. These symptoms developed in the first hour of intoxication. The hepatic...

  • The puzzling inflammatory bowel disease: growing interest for mediators of inflammation. Zijlstra, F. J. // Mediators of Inflammation;Apr97, Vol. 6 Issue 2, p83 

    Introduces articles published in the April 1997 issue of the 'Mediators of Inflammation' journal. Inflammatory bowel disease mediators; T cell proliferation and production of T cell-derived cytokines; Reduction of T cell migration.

  • Cancer immunotherapy: potential involvement of mediators. Ben-Efraim, S. // Mediators of Inflammation;Jun97, Vol. 6 Issue 3, p163 

    The description of a cell-free soluble anti-tumour factor by Carswell et al. in 1975 (Proc Natl Acad Sci USA, 72: 3666 - 3670) was followed by a long series of experimental and clinical investigations into the role of cell-free mediators in cancer immunotherapy. These investigations included...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics